Riskpilot← Back to searchSign inGet full accessBauder Vårdkonsult AB
ABBankruptOrg 5592591001Hospital activities · NACE 8610Est. 20200 employees
Revenue 2023
SEK 6M
+168% vs 2022
EBITDA margin
23.6%
+503% vs 2022
Equity ratio
54.2%
Financial strength
Net profit 2023
SEK 210K
+55% vs 2022
| Revenue | SEK 6M | +168% |
| EBITDA | SEK 1,4M | +503% |
| Net profit | SEK 210K | +55% |
| Total assets | SEK 851K | +30% |
| Equity | SEK 461K | +84% |
| Employees | 0 | — |
Legal name
Bauder Vårdkonsult AB
Org number
5592591001
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
10 juni 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Styrelsen ska bestå av 1 styrelseledamot och 1 styrelsesuppleant.
Company purpose
Bolaget bedriver arbete inom hälso- och sjukvård på olika fronter. Drift av hälsokliniker där man fackmannamässigt bedriver arbete för främjande av människors hälsa och välmående. Bolaget samordnar också produktion och försäljning av egna hälsofrämjande kosttillskott och hälsokost. Parallell bedrift av bemannings- och konsultverksamhet inom öppen och sluten hälso- och sjukvård hos kommunala och regionala verksamheter.
Address
Phone
+4654150140
Email
dk.redovisning@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue | 1 843 | 2 237 | 5 987 |
| Staff expenses | — | −1 102 | — |
| EBITDA | 119 | 234 | 1 411 |
| Depreciation & amort. | −0 | −10 | −10 |
| EBIT | 119 | 224 | 1 401 |
| Net financials | 20 | −0 | −2 |
| Profit before tax | 109 | 174 | 265 |
| Tax | −19 | −39 | −55 |
| Net profit | 90 | 135 | 210 |
| Item | 2021 | 2022 | 2023 |
|---|---|---|---|
| Total assets | 323 | 655 | 851 |
| Equity | 115 | 251 | 461 |
| Long-term debt | 0 | — | 0 |
| Short-term debt | 177 | 324 | 236 |
| Total debt | 177 | 324 | 236 |
EBITDA margin
23.6%
This company
15.8%
Market median
+49% vs market
20212023
Equity ratio
54.2%
This company
38.2%
Market median
+42% vs market
20212023
Return on equity
45.6%
This company
18.4%
Market median
+148% vs market
20212023
Net profit margin
3.5%
This company
8.1%
Market median
-57% vs market
20212023
Asset turnover
7.04×
This company
1.12×
Market median
+529% vs market
20212023
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20212023
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
DK External Signatory | External Signatory | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
| Former (4) | ||
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2024 – 2024 | |
| Deputy Board Member | 2024 – 2024 | |
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bauder Vårdkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dzevdet Kurti | External Signatory | 0 companies |
| Sai Victor Bauder Fonturvel | Board of Directors | 0 companies |
| Arber Kurti | Deputy Board Member | 0 companies |
| Kemal Ucak | Deputy Board Member | 0 companies |
| Ingegerd Margareta Bauder Fonturvel | Deputy Board Member | 0 companies |
| Ömer Asan | Board of Directors | 0 companies |